Fastorab-LSR 20/75 Capsule belongs to a group of medicines called gastrointestinal agents used to treat gastro-oesophageal reflux disease (GERD), acidity, heartburn, Zollinger-Ellison syndrome, Helicobacter pylori infection, irritable bowel syndrome, indigestion, duodenal and gastric ulcers. The stomach is usually protected from acid by a mucous layer. In some cases, due to excess acid production, the mucous layer gets eroded, which leads to acidity. 
 
Fastorab-LSR 20/75 Capsule is a combination of two drugs, namely: Rabeprazole (proton pump inhibitor) and Levosulpiride (prokinetic agent). Rabeprazole works by blocking an enzyme called the gastric proton pump, which is responsible for acid production. Levosulpiride works by increasing the pressure of the inferior oesophageal (food pipe) sphincter, thereby preventing the backflow of food and acid into the mouth. Together, Fastorab-LSR 20/75 Capsule helps in preventing acid reflux, thereby providing relief from acidity and heartburn.
 
You are advised to take Fastorab-LSR 20/75 Capsule for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side-effects such as headache, nausea, vomiting, gas, abdominal pain, dizziness, and diarrhoea. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
 
Inform your doctor if you have a history of gastrointestinal bleeding or intestinal obstruction. On long-term treatment, Fastorab-LSR 20/75 Capsule may cause osteoporosis and hypomagnesemia. Consult a doctor if you are pregnant or breastfeeding. Fastorab-LSR 20/75 Capsule may cause drowsiness and dizziness, so drive only if you are alert. Fastorab-LSR 20/75 Capsule is not recommended for children as safety and effectiveness have not been established. Avoid consuming alcohol along with Fastorab-LSR 20/75 Capsule as it could lead to increased drowsiness and elevate stomach acid production. 

Fastorab-LSR 20/75 Capsule is a combination of two drugs, namely: Rabeprazole and Levosulpiride. Fastorab-LSR 20/75 Capsule belongs to a group of medicines called gastrointestinal agents used to treat gastro-oesophageal reflux disease (GERD), acidity, heartburn, Zollinger-Ellison syndrome, Helicobacter pylori infection, irritable bowel syndrome, indigestion, duodenal and gastric ulcers. Rabeprazole is a proton pump inhibitor that works by blocking an enzyme called gastric proton pump, which is responsible for the production of acid. Levosulpiride is a prokinetic agent that increases the pressure of the inferior oesophageal (food pipe) sphincter, thereby preventing the backflow of food and acid into the mouth. Together, Fastorab-LSR 20/75 Capsule helps in preventing acid reflux, thereby providing relief from acidity and heartburn. 

Do not take Fastorab-LSR 20/75 Capsule if you are allergic to any of its components. Inform your doctor if you have a history of pheochromocytoma (tumour of the adrenal gland), epilepsy, mania, gastrointestinal bleeding, intestinal obstruction, or severe kidney or liver impairment. Fastorab-LSR 20/75 Capsule may cause osteoporosis (weak and brittle bones) and hypomagnesemia (low magnesium levels) on long-term treatment. Consult a doctor if you are pregnant or breastfeeding. Fastorab-LSR 20/75 Capsule may cause dizziness and drowsiness, so drive only if you are alert. Fastorab-LSR 20/75 Capsule is not recommended for children as safety and effectiveness have not been established.

• Fastorab-LSR 20/75 Capsule might cause false-positive results for secretin stimulation test, prolactin test, and tests for tetrahydrocannabinol (THC). Inform the person doing the tests that you are taking Fastorab-LSR 20/75 Capsule .
• Regular blood tests for monitoring magnesium levels and bone density tests are advised if you are on long-term treatment with Fastorab-LSR 20/75 Capsule .
• Inform your doctor if you are due to have Chromogranin A test.